DOI: 10.12890/2023_003711

Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Authors

  • Justine Chinnappan Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Murtaza Hussain Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Dominic Awuah Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Ekwevugbe Ogbon Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Ghassan Bachuwa Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Philip McDonald Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA; Division of Infectious Disease, Michigan State University at Hurley Medical Center, Flint, MI, USA

justineirene@gmail.com

Keywords

Extraintestinal CDI, abdominal wall abscess, persistent C. difficile abscess

Abstract

Clostridioides (formerly Clostridium) difficile infection is a common and costly healthcare-associated infection. Extraintestinal C. difficile infection is rarely encountered, especially in isolation. We present a unique case of abdominal wall abscess presenting six months following gastrointestinal (GI) surgery. The patient was managed with computed tomography (CT) guided drainage of the abscess, placement of a drainage catheter, and aggressive broad-spectrum antibiotic treatment for a prolonged duration over multiple admissions. 

View the entire article

Downloads

References

  1. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372:1539-1548.
  2. Gupta, A., Patel R, Baddour LM, Pardi DS, Khanna S. Extraintestinal Clostridium difficile infections: a single-center experience. Mayo Clin Proc 2014;89:1525-1536.
  3. Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine (Baltimore), 2001;80:88-101.
  4. Amaya S-L, Rosa E-S, Sergio G-F, Noelia A, Lourdes R-R, Eduardo G, et al. Extraintestinal Clostridioides difficile infection: septic arthritis 12 months after colitis. Anaerobe 2021;69:102318.
  5. Hudson DA, Gibb AP, Gill MJ. Empyema caused by Clostridium difficile. Can J Infect Dis, 1999;10:170-171.
  6. Johnson S, Lavergne V, Skinner AM, Gonzales-Luma AJ, Garey KW, Kelly CP, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 2021;73:e1029-e1044. doi: 10.1093/cid/ciab549
  7. Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Beldavs ZG, Farley MM, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020;382:1320-1330.
  8. Forrester JD, Maggio PM, Tennakoon L. Cost of health care-associated infections in the United States. J Patient Saf 2022;18:e477-e479.
  9. Qu HQ, Jiang ZD. Clostridium difficile infection in diabetes. Diabetes Res Clin Pract 2014;105:285-294. doi:10.1016/j.diabres.2014.06.002
  10. Durojaiye O, Gaur S, Alsaffar, L. Bacteraemia and breast abscess: unusual extra-intestinal manifestations of Clostridium difficile infection. J Med Microbiol 2011;60 (Pt 3):378-380.
  11. García-Lechuz JM, Hernangómez RSJ, Peláez T, Alcalá L, Bouza E. Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect 2001;7:453-457.
  12. Wolf LE, Gorbach SL, Granowitz EV. Extraintestinal Clostridium difficile: 10 years’ experience at a tertiary-care hospital. Mayo Clin Proc 1998;73:943-947.
  13. Gardiner BJ, Thorpe CM, Pinkham, NV, McDermott LA, Walk ST, Snydman DR. A repeat offender: recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation. Anaerobe 2018;51:68-72.
  14. Herberts M, Hicks B, Sohail MR, Jagtiani A. Secondary bacterial peritonitis and pelvic abscess due to Clostridium difficile. BMJ Case Rep 2018;2018.
  15. Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila V-J. Extraintestinal Clostridium difficile infections. Clin Infect Dis 2013;57:e148-53.
  16. Basnet N, Thapaliya S, Shrotriya S, Kar P, Mitra S. Extraintestinal Clostridium difficile infection: scrotal abscess. Anaerobe 2020;61:102147.
  17. Babar S, Kurdi BE, Iskandarani ME, Haddad I, Imam Z, Alomari M, et al. Oral vancomycin prophylaxis for the prevention of Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2020;41:1302-1309.
  18. Tariq R, Laguio-Vila M, Tahir MW, Orenstein R, Pardi DS, Khanna S. et al. Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis. Therap Adv Gastroenterol 2021;14:1756284821994046.
  19. Zhang K, Beckett P, Abouanaser S, Stankus V, Lee C. Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection. BMC Infect Dis 2019;19:51.

Published

2023-02-03

Issue

Vol. 10 No. 1 (2023)

Categories

How to Cite

1.
Chinnappan J, Murtaza Hussain, Dominic Awuah, Ekwevugbe Ogbon, Ghassan Bachuwa, Philip McDonald. Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess. EJCRIM [Internet]. 2023 Feb. 3 [cited 2026 Nov. 3];10(1). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3711

Most read articles by the same author(s)